ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sangamo, Pfizer announce updated Phase 1/2 results for SB-525 investigational Hemophilia A gene therapy
July 08, 2019In addition to the collaboration for the development and commercialization of gene therapies for hemophilia A, Sangamo and Pfizer are also working together on the development of gene therapies for amyotrophic lateral sclerosis (ALS) and frontotemporal lob
Pharma Sources Insight January 2025
